GZMA and tuberculosis: Thus, future TB vaccine or therapeutic strategies should maximize the induction of mycobacteria-specific, granzyme A-producing γ9δ2 T cells and thereby favor the early and enhanced production of TNF-α in mycobacteria-infected and bystander macrophages in response to TB challenge.